Elevated basal FSH in normal cycling women is associated with unfavourable lipid levels and increased cardiovascular risk

Human Reproduction

Volumn 18, Issue 8, 2003, Pages 1570-1573

  Chu, Micheline C ^a   Rath, Kristina M ^a   Huie, Jennifer ^a   Taylor, Hugh S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Cholesterol; FSH; Lipids; Ovary

Indexed keywords

CHOLESTEROL; ESTRADIOL; ESTROGEN; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN; HORMONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIET RESTRICTION; ESTROGEN DEFICIENCY; FEMALE; FOLLITROPIN BLOOD LEVEL; HEART PROTECTION; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MENSTRUAL CYCLE; OVARY FUNCTION; PREMENOPAUSE; PREVALENCE; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

FALLOPIA;

EID: 0043125556     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deg330     Document Type: Article

References (23)

1. American Heart Association (1998) Heart and Stroke Facts: Statistical Update. Dallas, TX.
2. Barrett-Connor, E. (1997) Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation, 95, 252-264.
3. Berenson, G.S., Srinivasan, S.R., Bao, W., Newman, W.P. 3rd, Tracy, R.E. and Wattigney, W.A. (1998) Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N. Engl. J. Med., 338, 1650-1656.
4. Bopp, B.L. and Seifer, D.B. (1998) Oocyte loss and the perimenopause. Clin. Obstet. Gynecol., 41, 898-911.
5. Creus, M., Penarrubia, J., Fabregues, F., Vidal, E., Carmona, F., Casamitjana, R., Vanrell, J.A. and Balasch, J. (2000) Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum. Reprod., 15, 2341-2346.
6. De Aloysio, D., Gambacciani, M., Meschia, M., Pansini, F., Bacchi Modena, A., Bolis, P.F., Massobrio, M., Maiocchi, G. and Peruzzi, E. (1999) The effect of menopause on blood lipid and lipoprotein levels. The Icarus Study Group. Atherosclerosis, 147, 147-153.
7. Grady, D., Herrington, D., Bittner, V., Blumenthal, R., Davidson, M., Hlatky, M., Hsia, J., Hulley, S., Herd, A., Khan, S. et al. (2002) Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and estrogen/progestin replacement study follow-up (HERS II). JAMA, 288, 49-57.
8. Grodstein, F., Stampfer, M.J., Colditz, G.A., Willett, W.C., Manson, J.E., Joffe, M., Rosner, B., Fuchs, C., Hankinson, S.E., Hunter, D.J. et al. (1997) Postmenopausal hormone therapy and mortality. N. Engl. J. Med., 336, 1769-1775.
9. Grundy, S.M., Pasternak, R., Greenland, P., Smith, S. Jr and Fuster, V. (1999). Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation, 100, 1481-1492.
10. Hulley, S., Grady, D., Bush, T., Furberg, C., Herrington, D., Riggs, B. and Vittinghoff, E. (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA, 280, 605-613.
11. Klein, N. A. and Soules, M.R. (1998) Endocrine changes of the perimenopause. Clin. Obstet. Gynecol., 41, 912-920.
12. Lee, S.J., Lenton, E.A., Sexton, L. and Cooke, I.D. (1988) The effect of age on the cyclical patterns of plasma LH, FSH, oestradiol and progesterone in women with regular menstrual cycles. Hum. Reprod., 3, 851-855.
13. Matthews, K.A., Meilahn, E., Kuller, L.H., Kelsey, S.F., Caggiula, A.W. and Wing, R.R. (1989) Menopause and risk factors for coronary heart disease. N. Engl. J. Med., 321, 641-646.
14. Pellicer, A., Ardiles, G., Neuspiller, F., Remohi, J., Simon, C. and Bonilla-Musoles, F. (1998) Evaluation of the ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography. Fertil. Steril., 70, 671-675.
15. Reame, N.E., Kelche, R.P., Beitins, I.Z., Yu, M.Y., Zawacki, C.M. and Padmanabhan, V. (1996) Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women. J. Clin. Endocrinol. Metab., 81, 1512-1518.
16. Rossouw, J.E., Anderson, G.L., Prentice, R.L., LaCroix, A.Z., Kooperberg, C., Stefanick, M.L., Jackson, R.D., Beresford, S.A., Howard, B.V., Johnson, K.C. et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA, 288, 321-333.
17. Santoro, N., Banwell, T., Tortoriello, D., Lieman, H., Adel, T. and Skurnick, J. (1998) Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women. Am. J. Obstet. Gynecol., 179, 732-741.
18. Scott, R.T., Toner, J.P., Muasher, S.J., Oehninger, S., Robinson, S. and Rosenwaks, Z. (1989) Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil. Steril., 51, 651-654.
19. Seifer, D.B., Scott, R.T. Jr, Bergh, P.A., Abrogast, L.K., Friedman, C.I., Mack, C.K. and Danforth, D. R. (1999) Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone. Fertil. Steril., 72, 63-65.
20. Stamler, J., Daviglus, M.L., Garside, D.B., Dyer, A.R., Greenland, P. and Neaton, J.D. (2000) Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA, 284, 311-318.
21. The Writing Group for the PEPI Trial (1995) Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA, 273, 199-208.
22. Toner, J.P., Philput, C.B., Jones, G.S. and Muasher, S.J. (1991) Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil. Steril., 55, 784-791.
23. Wild, R.A. (1998) Risk factors: Assessment and preventive measures. Clin. Obstet. Gynecol., 41, 966-975.